# The Effect of Celecoxib on Neuroinflammation in MDD

> **NCT04814355** · PHASE4 · COMPLETED · sponsor: **Stony Brook University** · enrollment: 41 (actual)

## Conditions studied

- Major Depressive Disorder
- Neuroinflammation

## Interventions

- **DRUG:** Celecoxib 400 mg

## Key facts

- **NCT ID:** NCT04814355
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-01
- **Primary completion:** 2025-08-11
- **Final completion:** 2026-02-28
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04814355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04814355, "The Effect of Celecoxib on Neuroinflammation in MDD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04814355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*